$0.10 EPS Expected for Biosyent Inc. (RX)

November 12, 2017 - By Louis Casey

 $0.10 EPS Expected for Biosyent Inc. (RX)

Analysts await Biosyent Inc. (CVE:RX) to report earnings on November, 22. They expect $0.10 earnings per share, up 25.00 % or $0.02 from last year’s $0.08 per share. V_RX’s profit will be $1.45 million for 25.75 P/E if the $0.10 EPS becomes a reality. After $0.11 actual earnings per share reported by Biosyent Inc. for the previous quarter, Wall Street now forecasts -9.09 % negative EPS growth. The stock decreased 0.96% or $0.1 on November 10, reaching $10.3. About 1,605 shares traded. Biosyent Inc. (CVE:RX) has 0.00% since November 12, 2016 and is . It has underperformed by 16.70% the S&P500.

BioSyent Inc. is a specialty pharmaceutical company. The company has market cap of $149.26 million. The Company, through its subsidiary, BioSyent Pharma Inc., acquires or in-licenses and develops pharmaceutical products for sale in Canada and certain international markets. It has a 31.55 P/E ratio. It has four business units: the Community and Women’s Health Unit, which commercializes pharmaceutical products focused on improving family and women’s health; the Hospital Business Unit, which sells pharmaceutical products to hospitals and hospital specialists; the International Pharmaceutical Unit, and the Legacy Business.

More notable recent Biosyent Inc. (CVE:RX) news were published by: Marketwired.com which released: “BioSyent Pharma Announces the Canadian Launch of the First of 3 New Products …” on February 03, 2015, also Marketwatch.com with their article: “10.30” published on April 19, 2011, Seekingalpha.com published: “BioSyent: A High Growth Niche Pharma Company With Some Catalysts For …” on June 17, 2015. More interesting news about Biosyent Inc. (CVE:RX) were released by: Globenewswire.com and their article: “BioSyent Releases Q2 and H1 2017 Results - CORRECTION” published on August 16, 2017 as well as Globenewswire.com‘s news article titled: “BioSyent Schedules Q3 2017 Earnings Release for November 15, 2017” with publication date: November 08, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Twitter Auto Publish Powered By : XYZScripts.com